RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism

Abstract

We have generated RANK (receptor activator of NF-B) nullizygous mice to determine the molecular genetic interactions between osteoprotegerin, osteoprotegerin ligand, and RANK during bone resorption and remodeling processes. RANK ؊/؊ mice lack osteoclasts and have a profound defect in bone resorption and remodeling and in the development of the cartilaginous growth plates of endochondral bone. The osteopetrosis observed in these mice can be reversed by transplantation of bone marrow from rag1 ؊/؊ (recombinase activating gene 1) mice, indicating that RANK ؊/؊ mice have an intrinsic defect in osteoclast function. Calciotropic hormones and proresorptive cytokines that are known to induce bone resorption in mice and human were administered to RANK ؊/؊ mice without inducing hypercalcemia, although tumor necrosis factor ␣ treatment leads to the rare appearance of osteoclast-like cells near the site of injection. Osteoclastogenesis can be initiated in RANK ؊/؊ mice by transfer of the RANK cDNA back into hematopoietic precursors, suggesting a means to critically evaluate RANK structural features required for bone resorption. Together these data indicate that RANK is the intrinsic cell surface determinant that mediates osteoprotegerin ligand effects on bone resorption and remodeling as well as the physiological and pathological effects of calciotropic hormones and proresorptive cytokines.B one remodeling and homeostasis is an essential function that regulates skeletal integrity throughout adult life in higher vertebrates and mammals. The maintenance of skeletal mass is controlled by the activities of specialized cells within the bone that have seemingly antagonistic activities: bone synthesis and bone resorption. Osteoblastic cells of mesenchymal origin synthesize and deposit bone matrix and increase bone mass. Osteoclastic cells are large, multinucleated phagocytes of hematopoietic origin that resorb both mature and newly synthesized bone upon activation. Bone synthesis and resorption processes are highly coordinated and are regulated by osteotropic and calciotropic hormones during physiological and pathological conditions (1, 2). Increased bone resorption and turnover mediated by activated osteoclasts is known to occur in various crippling diseases, such as osteoporosis and arthritis, and can lead to pathological decreases in bone mass and skeletal integrity.Recently, two critical extracellular regulators of osteoclast differentiation and activation have been identified: osteoprotegerin (OPG) (3) and OPG ligand (OPGL) (4). OPGL is a tumor necrosis factor (TNF)-related cytokine that stimulates osteoclast differentiation from hematopoietic precursor cells and activation of mature osteoclasts in vitro and in vivo. Mice lacking OPGL also lack osteoclasts and have defects in bone remodeling processes that leads to severe osteopetrosis (5). OPG is a secreted TNF receptor (TNFR)-related protein that binds to and neutralizes OPGL bioactivity. Transgenic mice that overexpress OPG also have defects in osteoclastogenesis similar t...

Screening the genome for rheumatoid arthritis susceptibility genes: A replication study and combined analysis of 512 multicase families

“…For example, one possible candidate gene on chromosome 18q21 is the TNFRSF11A gene, which encodes receptor activator of nuclear factor B (RANK). RANK has been shown to be critically involved in the differentiation of osteoclasts in inflamed synovium and is clearly important for the development of bone resorption in inflammatory arthritis (39). Because the NARAC collection is specifically selected for erosive RA, our patient population is well suited to detect genes involved in the pathogenesis of bony erosions.…”

Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis

“…In this study, we have shown that TNFa may promote the osteolysis of aseptic loosening by directly inducing arthroplasty-derived macrophages to differentiate into osteoclasts. A role for TNFa stimulation of osteoclast formation was suggested by the studies of Li et al who found that TNFa treatment leads to the formation of osteoclasts near the site of injection in RANK knockout mice (RANK-/-) which have a form of osteopetrosis characterized by an absence of osteoclasts [34]. It has recently been found that MNCs expressing the cytochemical characteristics of osteoclasts can be formed from mouse marrow precursors in the presence of M-CSF when TNFa is substituted for RANKL [26], but that these MNCs are not capable of lacunar resorption unless 1L-lr is also present.…”

The pathogenesis of the bone disease of multiple myeloma

“…The interaction between RANKL and RANK is critical in the formation and activation of osteoclasts, and inhibition by OPG results in inhibition of bone resorption. The critical role of these TNF family members is highlighted by in vivo studies where mice deficient in RANK or RANKL have extensive osteopetrosis due to a lack of functional osteoclasts (17,18), whereas OPG knock out mice have severe osteoporosis (19).…”